Mårten Fernö

191 – 200 of 258

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/onk-mfe?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
19
20
21
22
…
26
next »

2000
Mark Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast
Ringberg, Anita ^LU ; Idvall, Ingrid ^LU ; Fernö, Mårten ^LU ; Anderson, Harald ^LU ; Anagnostaki, L ; Boiesen, P ; Bondesson, L ; Holm, E ; Johansson, S and Lindholm, K , et al. (2000) In European Journal of Surgical Oncology 26(5). p.444-451
- Contribution to journal › Article
Mark ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer
Stål, O ; Borg, A ; Fernö, M ^LU ; Källström, A C ; Malmström, P ^LU and Nordenskjöld, B (2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(12). p.1545-1550
- Contribution to journal › Article
1999
Mark Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
Rudolph, P ; Alm, P ^LU ; Heidebrecht, H J ; Bolte, H ; Ratjen, V ; Baldetorp, B ^LU ; Fernö, M ^LU ; Olsson, H ^LU and Parwaresch, R (1999) In Journal of the National Cancer Institute 91(3). p.8-271
- Contribution to journal › Article
Mark Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas : prognostic implications
Rudolph, P ; Olsson, Håkan ^LU ; Bonatz, G ; Ratjen, V ; Bolte, H ; Baldetorp, B ^LU ; Fernö, M ^LU ; Parwaresch, R and Alm, P ^LU (1999) In Journal of Pathology 187(2). p.16-207
- Contribution to journal › Article
Mark Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients
Jernström, Helena ^LU ; Frenander, J ; Fernö, Mårten ^LU and Olsson, Håkan ^LU (1999) In British Journal of Cancer 80(9). p.1453-1458
- Contribution to journal › Article
Mark Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications
Rudolph, P ; Olsson, Håkan ^LU ; Bonatz, G ; Ratjen, V ; Bolte, H ; Baldetorp, Bo ^LU ; Fernö, Mårten ^LU ; Parwaresch, R and Alm, P (1999) In Journal of Pathology 187(2). p.207-276
- Contribution to journal › Article
Mark Prognostic implications of various models for calculation of S-phase fraction in 259 patients with soft tissue sarcoma
Gustafson, Pelle ^LU ; Baldetorp, Bo ^LU ; Fernö, Mårten ^LU and Åkerman, Måns ^LU (1999) In British Journal of Cancer 79. p.1205-1209
- Contribution to journal › Article
Mark Vascular endothelial growth factor (VEGF) and urokinase plasminogen activator (uPA) are independent prognostic factors for distant recurrence in premenopausal node-negative breast cancer
Linderholm, B. ; Gruvberger, S ^LU ; Fernö, M ^LU ; Bendahl, P-O ^LU and Malmström, Per ^LU (1999) In Breast Cancer Research and Treatment 57(1). p.98-98
- Contribution to journal › Published meeting abstract
Mark Estrogen receptor content in adenovirus type 9-induced rat mammary tumors
Ankerst, Jaro ^LU ; Fernö, Mårten ^LU and Jonsson, Nils ^LU (1999) In In Vivo 13(2). p.151-153
- Contribution to journal › Article
1998
Mark Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group
Baldetorp, Bo ^LU ; Stal, O ; Ahrens, O ; Cornelisse, C ; Corver, W ; Falkmer, U and Fernö, Mårten ^LU (1998) In Cytometry 33(4). p.385-393
- Contribution to journal › Article

« previous
1
…
19
20
21
22
…
26
next »